40 Temple Street/Suite 5-B, New Haven, CT 06510, USA.
Br J Ophthalmol. 2010 May;94(5):559-63. doi: 10.1136/bjo.2009.167346. Epub 2009 Dec 3.
BACKGROUND/AIMS To review the long-term results of treatment of optic nerve sheath meningiomas (ONSMs) with conformal radiotherapy. METHODS Eleven patients with presumed ONSM were treated with fractionated conformal radiotherapy using 45-54 Gy in 25-30 fractions and followed for more than 5 years. Affected eye visual acuity in logMAR notation, colour vision, threshold perimetry, mean deviation (dB) and imaging were studied before and after treatment. ANALYSIS Included adverse effects of treatment and the frequency of affected eye maintained or improved vision. RESULTS There were nine women and two men with a mean age of 45.3. Vision or field loss was the most common presentation. All had abnormal MR imaging. The follow-up period after radiotherapy was 61-156 months (mean 89.6). Visual acuity was unchanged or improved in 10 patients (91%). The average difference between pretreatment and final logMAR visual acuity was 0.08, while the average difference in visual-field mean deviation was -4.63 dB. The radiographic appearance of the tumours was stable in size in nine patients and decreased in two. No major side effects from radiation were seen. CONCLUSIONS Vision, MRI and complication outcomes are favourable for using fractionated conformal radiotherapy for ONSM.
背景/目的:回顾使用适形放疗治疗视神经鞘脑膜瘤(ONSM)的长期结果。
11 例疑似 ONSM 患者接受了 45-54 Gy 分 25-30 次分割的分次适形放疗,并随访超过 5 年。在治疗前后研究了受影响眼的视力(以 logMAR 记法表示)、色觉、阈值视野检查、平均偏差(dB)和影像学。
包括治疗的不良反应以及受影响眼视力保持或改善的频率。
有 9 名女性和 2 名男性,平均年龄为 45.3 岁。视力或视野丧失是最常见的表现。所有患者均有异常的 MRI 表现。放疗后随访时间为 61-156 个月(平均 89.6)。10 例患者的视力不变或改善(91%)。治疗前和最终 logMAR 视力的平均差异为 0.08,而视野平均偏差的平均差异为-4.63 dB。9 例患者肿瘤的影像学表现大小稳定,2 例减小。未观察到明显的放射性副作用。
对于 ONSM,使用分次适形放疗在视力、MRI 和并发症结果方面是有利的。